Astonea Labs (BOM:544409) Total Operating Expense: ₹263.3 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544409 Astonea Labs Ltd BOM:544409
12 GF Score
Price ₹273.75
! 4 Warning Signs
View Full Analysis

What is Astonea Labs Total Operating Expense?

Astonea Labs BOM:544409 12 Total Operating Expense is ₹263.3 Mil as of Mar. 2026. GuruFocus rates BOM:544409 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Astonea Labs's Total Operating Expense for the three months ended in Mar. 2026 was ₹263.3 Mil. Astonea Labs's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹263.3 Mil.

Astonea Labs Total Operating Expense Related Terms

Astonea Labs Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Astonea Labs's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astonea Labs Total Operating Expense Chart

Astonea Labs Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
62.83 80.57 102.14 135.12 340.16

Astonea Labs Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Sep25 Mar26
Total Operating Expense Get a 7-Day Free Trial 0.00 -7.85 38.98 0.00 263.30
BOM:544409
12GF Score
Astonea Labs Ltd BOM:544409
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astonea Labs Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹263.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹263.3 Mil mean?
Astonea Labs (BOM:544409) has a Total Operating Expense of ₹263.3 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Astonea Labs and its competitors.
Is Astonea Labs' Total Operating Expense too high?
Astonea Labs' current Total Operating Expense is ₹263.3 Mil. Overall, Astonea Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Astonea Labs' Total Operating Expense compare to ZTS?
Astonea Labs' Total Operating Expense of ₹263.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Astonea Labs and its competitors. Astonea Labs's current Total Operating Expense is ₹263.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astonea Labs stock overvalued right now?
Astonea Labs (BOM:544409) has a current Total Operating Expense of ₹263.3 Mil. The current Total Operating Expense is ₹263.3 Mil. Astonea Labs' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Astonea Labs (BOM:544409), the current Total Operating Expense is ₹263.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Astonea Labs Business Description

Address SCO 186-187, 2nd Floor, Cabin No. 306, SECTOR 8-C, Sector 8, Chandigarh, HR, IND, 160009
Astonea Labs Ltd is an India-based pharmaceutical and cosmetics company engaged in the manufacturing and development of healthcare and personal care products. The Company operates in the pharmaceuticals and cosmetics & personal care space, offering products that include generic medicines, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as skincare, haircare, anti-aging, ethical, and organic cosmetic products, supported by in-house research and development and contract manufacturing services. Its business activities are organized across key segments comprising Pharmaceuticals, Cosmetics & Personal Care, R&D & Innovation, and Contract Manufacturing (CDMO).
12GF Score

Get the complete analysis for BOM:544409

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹273.75
Price